tetrachlorophthalic anhydride: structure
tetrachlorophthalic anhydride : A cyclic dicarboxylic anhydride that is phthalic anhydride chlorinated at the 4-, 5-, 6- and 7-positions.
ID Source | ID |
---|---|
PubMed CID | 8326 |
CHEMBL ID | 1567912 |
CHEBI ID | 59097 |
SCHEMBL ID | 21861 |
MeSH ID | M0054065 |
Synonym |
---|
etrachlorophthalic acid anhydride |
CHEBI:59097 , |
phthalic anhydride, tetrachloro- |
tetrachlorophthalic anhydride |
nsc-1484 |
niagathal |
117-08-8 |
1,5,6,7-tetrachloroisobenzofuran |
nsc1484 |
1, 4,5,6,7-tetrachloro- |
4,5,6,7-tetrachloro-2-benzofuran-1,3-dione |
inchi=1/c8cl4o3/c9-3-1-2(8(14)15-7(1)13)4(10)6(12)5(3)1 |
1,3-isobenzofurandione, 4,5,6,7-tetrachloro- |
NCGC00091300-01 |
1,3-dioxy-4,5,6,7-tetrachloroisobenzofuran |
ai3-09048 |
brn 0211560 |
4,5,6,7-tetrachloro-1,3-isobenzofurandione |
einecs 204-171-4 |
ccris 6202 |
nsc 1484 |
nci-c61585 |
hsdb 2922 |
cp 626 |
tetrathal |
tetrachlorophthalic anhydride, 96% |
NCGC00091300-02 |
STK256922 |
AC-11123 |
FT-0657077 |
T0071 |
AKOS003239988 |
4,5,6,7-tetrakis(chloranyl)-2-benzofuran-1,3-dione |
A803707 |
4,5,6,7-tetrachloroisobenzofuran-1,3-dione |
NCGC00091300-03 |
BBL000527 |
unii-76glw0lbek |
76glw0lbek , |
5-17-11-00260 (beilstein handbook reference) |
ec 204-171-4 |
dtxcid606102 |
dtxsid7026102 , |
NCGC00256940-01 |
tox21_303212 |
cas-117-08-8 |
tox21_201740 |
NCGC00259289-01 |
EPITOPE ID:122674 |
tetrachlorophthalic anhydride [hsdb] |
tetrachlorophthalic acid anhydride |
tetrachloro-phthalic acid anhydride |
tetrachloro phthalic anhydride |
3,4,5,6-tetrachlorophthalic anhydride |
SCHEMBL21861 |
CHEMBL1567912 |
4,5,6,7-tetrachloro-2-benzofuran-1,3-dione # |
1,3-isobenzofurandione, tetrachloro- |
1,3-dioxo-4,5,6,7-tetrachloroisobenzofuran |
4,5,6,7-tetrachloro-isobenzofuran-1,3-dione |
tetrachloro-1,3-dihydro-2-benzofuran-1,3-dione |
J-514038 |
mfcd00005920 |
VS-00637 |
Q21045245 |
EN300-211008 |
Excerpt | Relevance | Reference |
---|---|---|
" The rats were orally dosed for 7 d with TCPA suspended in corn oil at 25, 100, 250, or 500 mg/kg." | ( Effect of tetrachlorophthalic anhydride on hepatic microsomal metabolism in rats and mice. Nair, RS; Ridley, WP; Warren, J, 1988) | 0.68 |
Role | Description |
---|---|
cross-linking reagent | A reagent with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between macromolecules, principally side chains of amino acids in proteins, allowing the locations of naturally reactive areas within the proteins to be identified. |
allergen | A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
cyclic dicarboxylic anhydride | An acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring. |
tetrachlorobenzene | Any member of the class of chlorobenzenes carrying four chloro groups at unspecified positions. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 39.8107 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 39.8107 | 0.0013 | 18.0743 | 39.8107 | AID926; AID938 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 76.9588 | 0.0030 | 41.6115 | 22,387.1992 | AID1159553 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 54.4827 | 0.0015 | 30.6073 | 15,848.9004 | AID1224848; AID1224849 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 61.7528 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 50.1187 | 0.0010 | 19.4141 | 70.9645 | AID588537 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 0.0016 | 0.0100 | 39.5371 | 1,122.0200 | AID588545 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 48.5577 | 0.0006 | 27.2152 | 1,122.0200 | AID743219 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (30.92) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (7.69%) | 6.00% |
Case Studies | 2 (15.38%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (76.92%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |